LLMpediaThe first transparent, open encyclopedia generated by LLMs

Arnie Charbonneau Cancer Institute

Generated by GPT-5-mini
Note: This article was automatically generated by a large language model (LLM) from purely parametric knowledge (no retrieval). It may contain inaccuracies or hallucinations. This encyclopedia is part of a research project currently under review.
Article Genealogy
Parent: City of Calgary Hop 5
Expansion Funnel Raw 65 → Dedup 0 → NER 0 → Enqueued 0
1. Extracted65
2. After dedup0 (None)
3. After NER0 ()
4. Enqueued0 ()
Arnie Charbonneau Cancer Institute
NameArnie Charbonneau Cancer Institute
Established2005
LocationCalgary, Alberta, Canada
TypeCancer research and treatment center
DirectorIan Tannock
AffiliationsUniversity of Calgary, Alberta Health Services

Arnie Charbonneau Cancer Institute is an academic cancer research and treatment center affiliated with University of Calgary and part of regional clinical networks in Alberta. The institute integrates translational research, clinical trials, and multidisciplinary care in collaboration with provincial and national organizations including Alberta Health Services, Canadian Cancer Society, and federal research agencies. Its mission aligns with international consortia and institutions such as National Cancer Institute (United States), Cancer Research UK, and leading academic centers.

History

The institute was founded amid provincial health initiatives connected to Province of Alberta investments and philanthropy by benefactors linked to Calgary civic leadership. Early partnerships involved academic units from University of Calgary Faculty of Medicine, clinical programs at Foothills Medical Centre, and research collaborations with institutes like European Organisation for Research and Treatment of Cancer and Canadian Institutes of Health Research. Over time the institute developed ties to consortia including Stand Up To Cancer, Canadian Cancer Trials Group, and the Pan-Canadian Oncology Drug Review. Leadership succession included clinician-scientists trained at institutions such as Memorial Sloan Kettering Cancer Center, MD Anderson Cancer Center, and Johns Hopkins Hospital.

Facilities and Location

Located on the University District, Calgary campus adjacent to clinical sites such as Foothills Medical Centre and the Tom Baker Cancer Centre, the institute occupies laboratory space, clinical trial units, and outpatient facilities. Infrastructure investments mirrored facility builds at institutions like BC Cancer, Princess Margaret Cancer Centre, and Vancouver General Hospital to support specialized platforms: genomics pipelines comparable to Broad Institute workflows, imaging suites with capacities similar to Mayo Clinic radiology services, and biobanking modeled after Ontario Institute for Cancer Research. Proximity to transportation nodes including Calgary International Airport facilitates national and international collaboration.

Research and Clinical Programs

Research programs span precision oncology, immunotherapy, radiation biology, molecular epidemiology, and survivorship studies. Translational teams work on targeted therapies influenced by discoveries from National Institutes of Health, trial designs used by European Society for Medical Oncology, and companion diagnostics developed in concert with the Canadian Agency for Drugs and Technologies in Health. Clinical trial portfolios include early-phase studies akin to Phase I clinical trial models, cooperative group trials with Canadian Cancer Trials Group, and investigator-initiated studies reflecting methodologies from Translational Research centers. Collaborations include projects with Genome Canada, BC Cancer Agency, Ontario Institute for Cancer Research, and international labs at Cambridge University Hospitals and University of Oxford.

Education and Training

Educational initiatives integrate graduate training through the Cumming School of Medicine, residency rotations connected to Royal College of Physicians and Surgeons of Canada accreditation, and postdoctoral fellowships mirroring programs at Dana-Farber Cancer Institute. Professional development includes continuing medical education aligned with standards from American Society of Clinical Oncology and European Society for Medical Oncology. The institute hosts workshops, seminars, and symposiums featuring speakers from Harvard Medical School, Stanford University School of Medicine, University of Toronto, and McGill University.

Patient Care and Services

Clinical services emphasize multidisciplinary tumor boards similar to models at Princess Margaret Cancer Centre and integrated palliative care pathways used by St. Michael's Hospital. Services include outpatient chemotherapy clinics, radiation oncology programs informed by protocols from American Society for Radiation Oncology, genetic counseling with alignment to ClinGen standards, and survivorship programs paralleling initiatives at MD Anderson Cancer Center. Patient navigation, psychosocial oncology, and rehabilitation services collaborate with community organizations such as Alberta Cancer Foundation and support groups affiliated with Canadian Cancer Society.

Funding and Partnerships

Funding sources combine provincial health funding, philanthropic gifts from regional donors, and competitive grants from agencies including Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council, and federal programs modeled on Canada Foundation for Innovation. Industry partnerships have included collaborations with biotechnology companies and pharmaceutical firms active in oncology trials such as Pfizer, Roche, and Bristol Myers Squibb while engaging contract research organizations similar to Parexel. Academic partnerships extend to institutions like University of British Columbia, University of Alberta, McMaster University, and international centers including Institut Gustave Roussy.

Notable Achievements and Awards

Notable achievements encompass contributions to translational discoveries recognized in journals cited by Nature Medicine, The Lancet Oncology, and Journal of Clinical Oncology; competitive awards to investigators from bodies such as Canadian Cancer Society Research Institute and CIHR. The institute’s teams have led multicenter trials incorporated into guidelines from NCCN Guidelines, influenced provincial formularies reviewed by the Pan-Canadian Oncology Drug Review, and earned recognition through regional research excellence awards and national investigator awards linked to organizations like Royal Society of Canada.

Category:Cancer research institutes in Canada